(Q53515118)

15 May 2018

title

FDG-PET after 1 cycle of therapy predicts outcome in diffuse large cell lymphoma and classic Hodgkin disease. (English)

1 reference

15 May 2018

author name string

Lale Kostakoglu

1

1 reference

15 May 2018

Stanley J Goldsmith

2

1 reference

15 May 2018

John P Leonard

3

1 reference

15 May 2018

Paul Christos

4

1 reference

15 May 2018

Richard R Furman

5

1 reference

15 May 2018

Tamer Atasever

6

1 reference

15 May 2018

Angely Chandramouly

7

1 reference

15 May 2018

Sumeet Verma

8

1 reference

15 May 2018

Pratichi Kothari

9

1 reference

15 May 2018

Morton Coleman

10

1 reference

15 May 2018

language of work or name

English

0 references

publication date

1 December 2006

1 reference

15 May 2018

number of pages

10

1 reference

inferred from page(s)

published in

Cancer

1 reference

15 May 2018

volume

107

1 reference

15 May 2018

issue

11

1 reference

15 May 2018

page(s)

2678-2687

1 reference

15 May 2018

Prospective multicenter trial for the response-adapted treatment of high-grade malignant non-Hodgkin’s lymphomas: Updated results of the COP-BLAM/IMVP-16 protocol with randomized adjuvant radiotherapy

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22276

Early response to chemotherapy: a surrogate for final outcome of Hodgkin's disease patients that should influence initial treatment length and intensity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22276

Early 18F-labeled fluoro-2-deoxy-D-glucose positron emission tomography scanning in the lymphomas: changing the paradigms of treatments?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22276

7 January 2021

Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22276

7 January 2021

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22276

7 January 2021

A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22276

7 January 2021

Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22276

7 January 2021

Early restaging positron emission tomography with ( 18)F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22276

7 January 2021

FDG-PET after two to three cycles of chemotherapy predicts progression-free and overall survival in high-grade non-Hodgkin lymphoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22276

7 January 2021

[18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in aggressive lymphoma: an early prognostic tool for predicting patient outcome.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22276

7 January 2021

FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22276

7 January 2021

Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22276

7 January 2021

Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22276

7 January 2021

Prognostic value of positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose ([18F]FDG) after first-line chemotherapy in non-Hodgkin's lymphoma: is [18F]FDG-PET a valid alternative to conventional diagnostic methods?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22276

7 January 2021

18FDG-PET following treatment as valid predictor for disease-free survival in Hodgkin's lymphoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22276

7 January 2021

Prognostic value of positron emission tomography in the evaluation of post-treatment residual mass in patients with Hodgkin's disease and non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22276

7 January 2021

Thoracic positron emission tomography using 18F-fluorodeoxyglucose for the evaluation of residual mediastinal Hodgkin disease

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22276

7 January 2021

Predictive role of positron emission tomography (PET) in the outcome of lymphoma patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22276

7 January 2021

Response assessment of aggressive non-Hodgkin's lymphoma by integrated International Workshop Criteria and fluorine-18-fluorodeoxyglucose positron emission tomography

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22276

7 January 2021

FDG-PET/CT in re-staging of patients with lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22276

7 January 2021

Chemotherapy for diffuse large-cell lymphoma--rapidly responding patients have more durable remissions

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22276

7 January 2021

Significance of a partial or slow response to front-line chemotherapy in the management of intermediate-grade or high-grade non-Hodgkin's lymphoma: a literature review

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22276

7 January 2021

Factors predicting long-term survival in low-risk diffuse large B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22276

7 January 2021

Identifiers

DOI

10.1002/CNCR.22276

1 reference

15 May 2018

release_fu6766esszdhrii5te7x4naokm

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/fu6766esszdhrii5te7x4naokm

24 November 2022

mapped directly with Wikidata item

1 reference

15 May 2018